Riskpilot← Back to searchSign inGet full accessLisoma AB
ABActiveOrg 5565308805Båtvägen 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19960 employees
Revenue 2025
SEK 0
EBITDA margin
—
-13% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
SEK 156K
+1518% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -17K | -13% |
| Net profit | SEK 156K | +1518% |
| Total assets | SEK 2,1M | -3% |
| Equity | SEK 2,1M | -3% |
| Employees | 0 | — |
Legal name
Lisoma AB
Org number
5565308805
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 maj 1996
Share capital
SEK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Rabe, Pia Gunborg Anette
Company purpose
Bolaget skall bedriva fastighetsförvaltning, agentur- och grossiströrelse avseende läkemedel, livsmedel och kosmetik, äga och förvalta aktier och därmed förenlig verksamhet.
Address
Båtvägen 18
Email
pia.rabe@lisoma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −21 | −678 | −14 | −15 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −21 | −678 | −14 | −15 | −17 |
| Net financials | — | — | — | 4 | 173 |
| Profit before tax | −21 | −678 | −14 | −11 | 156 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −21 | −678 | −14 | −11 | 156 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 484 | 2 621 | 2 411 | 2 205 | 2 137 |
| Equity | 3 479 | 2 616 | 2 406 | 2 200 | 2 132 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 5 | 5 | 5 | 5 |
| Total debt | 5 | 5 | 5 | 5 | 5 |
EBITDA margin
-1700000.0%
This company
15.8%
Market median
-10759594% vs market
20212025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20212025
Net profit margin
15600000.0%
This company
8.1%
Market median
+192592493% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lisoma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pia Gunborg Anette Rabe | Chairman | 0 companies |
| Sofie Florentina Rabe | Board of Directors | 0 companies |
| Linn Inger Margareta Rabe | Board of Directors | 0 companies |